ProMIS Neurosciences, Inc. (PMN)

ProMIS Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	63.81	6.12	13.29	12.6	5.88	16.94
Short-Term Investments	0.03	0.03	0.03	0.03	0.03	0.03
Cash & Short-Term Investments	63.85	6.15	13.32	12.63	5.91	16.98
Cash Growth	660.34%	-53.84%	5.49%	113.83%	-65.21%	1921.46%
Other Current Assets	1.76	3.03	5.59	0.99	1	0.74
Total Current Assets	65.61	9.18	18.91	13.62	6.9	17.71
Net Property, Plant & Equipment	-	-	-	-	0	0
Other Intangible Assets	-	-	-	-	0.02	0.03
Other Long-Term Assets	1.8	-	-	-	-	-
Total Assets	67.41	9.18	18.91	13.62	6.92	17.75
Accounts Payable	1.72	2.54	1.74	7.84	2.98	0.41
Accrued Expenses	4.9	7.87	0.48	1.51	3.44	0.52
Total Current Liabilities	6.61	10.41	2.22	9.35	6.41	0.93
Long-Term Debt	-	-	-	-	-	3.91
Other Long-Term Liabilities	0.08	0.03	0.2	0.52	1.86	7.25
Total Long-Term Liabilities	0.08	0.03	0.2	0.52	1.86	11.16
Total Liabilities	6.69	10.44	2.42	9.87	8.27	12.09
Additional Paid-in Capital	199.74	129.52	107.55	97.59	79.1	68.04
Accumulated Other Comprehensive Income	-0.37	-0.37	-0.37	-0.37	-0.2	-0.19
Retained Earnings	-138.65	-130.41	-90.69	-93.47	-80.25	-62.19
Shareholders' Equity	60.72	-1.26	16.49	3.75	-1.35	5.66
Total Liabilities & Equity	67.41	9.18	18.91	13.62	6.92	17.75
Total Debt	-	0	0	0	0	3.91
Net Cash (Debt)	63.85	6.15	13.32	12.63	5.91	13.07
Net Cash Growth	938.13%	-53.84%	5.49%	113.83%	-54.81%	1456.36%
Net Cash Per Share	20.51	3.50	12.59	25.69	19.68	56.48
Book Value	60.72	-1.26	16.49	3.75	-1.35	5.66
Book Value Per Share	19.50	-0.72	15.58	7.63	-4.49	24.46
Tangible Book Value	60.72	-1.26	16.49	3.75	-1.37	5.63
Tangible Book Value Per Share	19.50	-0.72	15.58	7.63	-4.56	24.34

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q